Search Results Search Sort by RelevanceMost Recent Case and Commentary Dec 2020 What Should We Do When Families Refuse Testing for Brain Death? Robert D. Truog, MD, MA, Wynne Morrison, MD, MBE, and Matthew Kirschen, MD, PhD Two commentaries respond to a case about apnea testing to confirm death by neurologic criteria. AMA J Ethics. 2020;22(12):E986-994. doi: 10.1001/amajethics.2020.986. Case and Commentary Apr 2021 Who Should Implement Force When It’s Needed and How Should It Be Done Compassionately? Matthew Lin, MD Covert medication administration might be as forceful as physical or chemical restraint for patients lacking insight. AMA J Ethics. 2021;23(4):E311-317. doi: 10.1001/amajethics.2021.311. Case and Commentary Apr 2021 在需要时应由谁实施强制措施,以及如何以富有同理心的方式实施? Matthew Lin(医学硕士) AMA J Ethics. 2021;E311-317. doi: 10.1001/amajethics.2021.311. Case and Commentary Apr 2021 ¿Quién debería aplicar la fuerza en caso de ser necesario y cómo hacerlo con compasión? Matthew Lin, MD AMA J Ethics. 2021;E311-317. doi: 10.1001/amajethics.2021.311. Case and Commentary Oct 2021 Holding Curative and Palliative Intentions Antoinette Esce, MD and Susan McCammon, MD, MFA Differentiating between best palliative care options and the curative and palliative potential of surgery is key to developing dual intentional clarity. AMA J Ethics. 2021;23(10):E766-771. doi: 10.1001/amajethics.2021.766. Case and Commentary Oct 2020 What Should Physicians Consider About American Indian/Alaska Native Women’s Reproductive Freedom? Felina Cordova-Marks, DrPH, MPH, Nikki Fennimore, MD, Amanda Bruegl, MD, and Jennifer Erdrich, MD, MPH For patients historically stripped of control over their reproductive health, consideration of past violations and transparent discussion are key. AMA J Ethics. 2020;22(10):E845-850. doi: 10.1001/amajethics.2020.845. Case and Commentary Nov 2020 Should a Good Risk Manager Worry About Cost and Price Transparency in Health Care? Josh Charles Hyatt, DHSc, MHL, MBE(c) and Stephen L. Newman, MD, MBA Once focused on hospital liability, risk managers now navigate a broader set of enterprise risk management responsibilities. AMA J Ethics. 2020;22(11):E924-932. doi: 10.1001/amajethics.2020.924. Case and Commentary Apr 2019 Should a Psychiatrist Prescribe a Nanodrug to Help Parents Monitor a Teen’s Adherence? Constance E. George, MD, MA Ethical stakes include a psychiatrist’s care management responsibilities and burdens borne by family members over the course of the patient’s care. AMA J Ethics. 2019;21(4):E317-323. doi: 10.1001/amajethics.2019.317. Case and Commentary Oct 2019 How Should a Physician Respond to a Patient’s Pain When New Opioid Prescribing Laws Limit Shared Decision Making? Alexander J. Hjelmaas, MD and Christian J. Vercler, MD, MA Regulations’ negative influence on patient-physician relationships can be mitigated by innovation in decision science. AMA J Ethics. 2019;21(10):E838-843. doi: 10.1001/amajethics.2019.838. Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Next page Next › Last page Last »
Case and Commentary Dec 2020 What Should We Do When Families Refuse Testing for Brain Death? Robert D. Truog, MD, MA, Wynne Morrison, MD, MBE, and Matthew Kirschen, MD, PhD Two commentaries respond to a case about apnea testing to confirm death by neurologic criteria. AMA J Ethics. 2020;22(12):E986-994. doi: 10.1001/amajethics.2020.986.
Case and Commentary Apr 2021 Who Should Implement Force When It’s Needed and How Should It Be Done Compassionately? Matthew Lin, MD Covert medication administration might be as forceful as physical or chemical restraint for patients lacking insight. AMA J Ethics. 2021;23(4):E311-317. doi: 10.1001/amajethics.2021.311.
Case and Commentary Apr 2021 在需要时应由谁实施强制措施,以及如何以富有同理心的方式实施? Matthew Lin(医学硕士) AMA J Ethics. 2021;E311-317. doi: 10.1001/amajethics.2021.311.
Case and Commentary Apr 2021 ¿Quién debería aplicar la fuerza en caso de ser necesario y cómo hacerlo con compasión? Matthew Lin, MD AMA J Ethics. 2021;E311-317. doi: 10.1001/amajethics.2021.311.
Case and Commentary Oct 2021 Holding Curative and Palliative Intentions Antoinette Esce, MD and Susan McCammon, MD, MFA Differentiating between best palliative care options and the curative and palliative potential of surgery is key to developing dual intentional clarity. AMA J Ethics. 2021;23(10):E766-771. doi: 10.1001/amajethics.2021.766.
Case and Commentary Oct 2020 What Should Physicians Consider About American Indian/Alaska Native Women’s Reproductive Freedom? Felina Cordova-Marks, DrPH, MPH, Nikki Fennimore, MD, Amanda Bruegl, MD, and Jennifer Erdrich, MD, MPH For patients historically stripped of control over their reproductive health, consideration of past violations and transparent discussion are key. AMA J Ethics. 2020;22(10):E845-850. doi: 10.1001/amajethics.2020.845.
Case and Commentary Nov 2020 Should a Good Risk Manager Worry About Cost and Price Transparency in Health Care? Josh Charles Hyatt, DHSc, MHL, MBE(c) and Stephen L. Newman, MD, MBA Once focused on hospital liability, risk managers now navigate a broader set of enterprise risk management responsibilities. AMA J Ethics. 2020;22(11):E924-932. doi: 10.1001/amajethics.2020.924.
Case and Commentary Apr 2019 Should a Psychiatrist Prescribe a Nanodrug to Help Parents Monitor a Teen’s Adherence? Constance E. George, MD, MA Ethical stakes include a psychiatrist’s care management responsibilities and burdens borne by family members over the course of the patient’s care. AMA J Ethics. 2019;21(4):E317-323. doi: 10.1001/amajethics.2019.317.
Case and Commentary Oct 2019 How Should a Physician Respond to a Patient’s Pain When New Opioid Prescribing Laws Limit Shared Decision Making? Alexander J. Hjelmaas, MD and Christian J. Vercler, MD, MA Regulations’ negative influence on patient-physician relationships can be mitigated by innovation in decision science. AMA J Ethics. 2019;21(10):E838-843. doi: 10.1001/amajethics.2019.838.
Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936.